Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Safety and Preliminary Efficacy of a Metabolically Armed Chimeric Antigen Receptor T Cell Therapy Targeting EGFRvIII for Recurrent Glioblastoma

Second Affiliated Hospital, Zhejiang University, School of Medicine · 2025
ClinicalTrials.gov · Datasets · License: Public Domain · 2025
Open Source ↗
glioblastoma (gbm), recurrent glioblastoma, egfrviii, metabolically armed, il-10, car-t cells therapy, interventional, early_phase1
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 1044894
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.